Gray Wealth Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Gray Wealth Management's PFE Position: Q4 2024 in Review
Gray Wealth Management reduced its Pfizer (PFE) stake by 14% in Q4 2024, selling an estimated $41.5K and leaving 9,461 shares worth $251K. The position accounts for 0.1% of the portfolio, ranked #111.
Gray Wealth Management first reported a position in PFE in Q4 2020 and has held it in 16 quarters since. The position peaked at $384K in Q4 2022. 2,995 funds tracked by Wall St. Rank hold PFE as of Q4 2024.
- Gray Wealth Management held 9,461 shares of Pfizer worth $251K as of Q4 2024.
- Gray Wealth Management sold 1,531 Pfizer shares in Q4 2024, an estimated $41.5K.
- Pfizer made up 0.1% of Gray Wealth Management's portfolio in Q4 2024, its #111 holding.
- Gray Wealth Management first reported a position in Pfizer in Q4 2020 and has held it in 16 quarters since.
- Gray Wealth Management's Pfizer position peaked at $384K in Q4 2022.
- 2,995 funds tracked by Wall St. Rank held Pfizer as of Q4 2024.
Based on Gray Wealth Management's 13F filing for Q4 2024, filed 10 Feb 2025.